COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 195 filers reported holding COHERUS BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $239 | -99.9% | 30,300 | -23.3% | 0.00% | -50.0% |
| Q3 2022 | $379,000 | +33.0% | 39,500 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $285,000 | -40.7% | 39,500 | +5.9% | 0.00% | -50.0% |
| Q1 2022 | $481,000 | -24.3% | 37,300 | -6.3% | 0.00% | 0.0% |
| Q4 2021 | $635,000 | -0.6% | 39,800 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $639,000 | +16.2% | 39,800 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $550,000 | -35.8% | 39,800 | -32.2% | 0.00% | -33.3% |
| Q1 2021 | $857,000 | +3.0% | 58,700 | +22.5% | 0.00% | 0.0% |
| Q4 2020 | $832,000 | +1748.9% | 47,900 | +1816.0% | 0.00% | – |
| Q3 2020 | $45,000 | +181.2% | 2,500 | +316.7% | 0.00% | – |
| Q3 2016 | $16,000 | +60.0% | 600 | 0.0% | 0.00% | – |
| Q2 2016 | $10,000 | -16.7% | 600 | 0.0% | 0.00% | – |
| Q1 2016 | $12,000 | -7.7% | 600 | 0.0% | 0.00% | – |
| Q4 2015 | $13,000 | – | 600 | – | 0.00% | – |
| Q1 2015 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q4 2014 | $39,000 | – | 2,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
| CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
| AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
| Knott David M Jr | 630,000 | $2,356 | 0.90% |
| COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
| Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
| Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
| Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |